The disease-specific pathway of multiple sclerosis (MS) signaling was upregulated across all YWH groups, marked by shared upregulation of interferon-responsive genes such as PARP9 and PARP14, indicating persistent immune activation despite viral suppression [94]. This evidence concerns the gene PARP9 and multiple sclerosis.